These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Salazopyrin EN-tabs: an enteric-coated case that is hard to take. Drug Ther Bull; 1987 Jul; 25(14):53-5. PubMed ID: 2886326 [No Abstract] [Full Text] [Related]
4. History of enteric coated sulfasalazine in rheumatoid arthritis. Pinals RS J Rheumatol Suppl; 1988 Sep; 16():1-4. PubMed ID: 2903922 [TBL] [Abstract][Full Text] [Related]
5. Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985. Drugs; 1986; 32 Suppl 1():1-80. PubMed ID: 2877848 [No Abstract] [Full Text] [Related]
6. Treatment of rheumatoid arthritis. Schinagl EF; Strauss PC N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778594 [No Abstract] [Full Text] [Related]
7. Gastric retention of enteric-coated sulfasalazine tablets. A complication of gastroduodenal Crohn's disease. Harary AM; Gluck CA; Rogers AI Dig Dis Sci; 1984 Nov; 29(11):1063-5. PubMed ID: 6149106 [TBL] [Abstract][Full Text] [Related]
8. Sulphasalazine and inflammatory bowel disease. Chapman P N Z Med J; 1987 Apr; 100(822):257. PubMed ID: 2901061 [No Abstract] [Full Text] [Related]
9. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets]. Amos RS Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988 [TBL] [Abstract][Full Text] [Related]
11. Interaction of omeprazole with enteric-coated salicylate tablets. Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060 [TBL] [Abstract][Full Text] [Related]
12. Enteric-coated insulin capsules: a combination with or a replacement of oral hypoglycaemic drugs. Hosny EA; el-Bagory IM; al-Jenoobi FI Boll Chim Farm; 2002; 141(5):379-84. PubMed ID: 12481381 [TBL] [Abstract][Full Text] [Related]
13. [Bioequivalency of salazosulfapyridine tablets]. Gafiţanu E; Matei I; Braha S; Vasilescu M; Mungiu OC Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):123-5. PubMed ID: 2899340 [No Abstract] [Full Text] [Related]
14. [Research on the formulation and quality evaluation of salazopyrine tablets]. Gafiţanu E; Matei I; Braha S; Vasilescu M; Cotleţ A Rev Med Chir Soc Med Nat Iasi; 1987; 91(1):141-4. PubMed ID: 2889248 [No Abstract] [Full Text] [Related]
15. Non-absorption of enteric-coated prednisolone. Normal absorption of non-enteric-coated prednisolone in a patient with Crohn's disease and massive intestinal resection. Olivesi A Therapie; 1985; 40(1):5-7. PubMed ID: 4002184 [No Abstract] [Full Text] [Related]
16. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations. Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man. Tanamai J; Veeramanomai S; Indrakosas N J Med Assoc Thai; 2004 Oct; 87(10):1156-61. PubMed ID: 15560690 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence. Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967 [TBL] [Abstract][Full Text] [Related]
19. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine. Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772 [TBL] [Abstract][Full Text] [Related]
20. [Gastric retention and enteric-coated tablets]. Eikeland O Tidsskr Nor Laegeforen; 1978 Feb; 98(6):306-7. PubMed ID: 635860 [No Abstract] [Full Text] [Related] [Next] [New Search]